These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 36147630)
1. Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma. He X; Xiao Y; Liu S; Deng R; Li Z; Zhu X Biomed Res Int; 2022; 2022():3191474. PubMed ID: 36147630 [TBL] [Abstract][Full Text] [Related]
2. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
3. Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma. Wang J; Bian Q; Liu J; Moming A Bioengineered; 2021 Dec; 12(2):10049-10062. PubMed ID: 34872450 [TBL] [Abstract][Full Text] [Related]
4. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma. Mao R; Chen Y; Xiong L; Liu Y; Zhang T Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878 [TBL] [Abstract][Full Text] [Related]
5. Necrotic related-lncRNAs: Prediction of prognosis and differentiation between cold and hot tumors in head and neck squamous cell carcinoma. Shi Y; Zhang Y; Zuo N; Wang L; Sun X; Liang L; Ju M; Di X Medicine (Baltimore); 2023 Jun; 102(23):e33994. PubMed ID: 37335630 [TBL] [Abstract][Full Text] [Related]
6. Identification and verification of aging-related lncRNAs for prognosis prediction and immune microenvironment in patients with head and neck squamous carcinoma. Gao Q; Shi Y; Sun Y; Zhou S; Liu Z; Sun X; DI X Oncol Res; 2023; 31(1):35-61. PubMed ID: 37303739 [TBL] [Abstract][Full Text] [Related]
7. A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinoma. Zhou W; Feng M; Qi F; Qiao J; Fan L; Zhang L; Hu X; Huang C Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):953-963. PubMed ID: 38063904 [TBL] [Abstract][Full Text] [Related]
8. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma. Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142 [TBL] [Abstract][Full Text] [Related]
9. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma. Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269 [TBL] [Abstract][Full Text] [Related]
10. Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma. Xu Z; Li X; Pan L; Tan R; Ji P; Tang H J Oral Pathol Med; 2022 Apr; 51(4):358-368. PubMed ID: 35100473 [TBL] [Abstract][Full Text] [Related]
11. Construction and validation of a prognostic signature based on seven endoplasmic reticulum stress-related lncRNAs for patients with head and neck squamous cell carcinoma. Zhou M; Li H; Hu J; Zhou T; Zhou L; Li Y Sci Rep; 2023 Dec; 13(1):22414. PubMed ID: 38104177 [TBL] [Abstract][Full Text] [Related]
12. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer. Zhang Z; Wang J; Han W; Zhao L BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatic analysis and verification of a lipid metabolism-related long noncoding RNA prognostic signature for head and neck squamous cell carcinoma. Yuan LY; Chen X; Pan KW; He Y; Li HY; Yu DS Cell Signal; 2023 Dec; 112():110903. PubMed ID: 37813294 [TBL] [Abstract][Full Text] [Related]
14. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma. Chen L; Cai Z; Lyu K; Cai Z; Lei W Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440 [TBL] [Abstract][Full Text] [Related]
15. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma. Cao W; Liu JN; Liu Z; Wang X; Han ZG; Ji T; Chen WT; Zou X Oral Oncol; 2017 Feb; 65():94-101. PubMed ID: 28109476 [TBL] [Abstract][Full Text] [Related]
16. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis. Qiang W; Dai Y; Xing X; Sun X Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800 [TBL] [Abstract][Full Text] [Related]
17. Constructing a Ferroptosis-related Long Non-coding RNA Signature to Predict the Prognostic of Head and Neck Squamous Cell Carcinoma Patients by Bioinformatic Analysis. Lu R; Li Z; Yin S Biochem Genet; 2022 Oct; 60(5):1825-1844. PubMed ID: 35098409 [TBL] [Abstract][Full Text] [Related]
19. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma. Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580 [TBL] [Abstract][Full Text] [Related]
20. An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma. Chen Y; Luo TQ; Xu SS; Chen CY; Sun Y; Lin L; Mao YP Cancer Med; 2021 Apr; 10(7):2268-2285. PubMed ID: 33660378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]